Allergan Inc.'s Botox Cosmetic As Actavis Plc Buys Drugmaker For $66 Billion
Branded boxes of Allergan Botox, produced by Allergan Inc., are arranged in this photograph taken at a skin and beauty clinic in London, U.K., on Monday, Nov. 17, 2014. Actavis Plc agreed to pay about $66 billion for Allergan Inc., a deal that creates a new top 10 drugmaker and ends Valeant Pharmaceuticals International Inc.'s attempt at a hostile takeover of the maker of Botox. Photographer: Jason Alden/Bloomberg via Getty Images
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesAllergan Inc.'s Botox Cosmetic As Actavis Plc Buys Drugmaker For $66..., News Photo
Allergan Inc.'s Botox Cosmetic As Actavis Plc Buys Drugmaker For $66... Get premium, high resolution news photos at Getty ImagesProduct #:459118974
Allergan Inc.'s Botox Cosmetic As Actavis Plc Buys Drugmaker For $66... Get premium, high resolution news photos at Getty ImagesProduct #:459118974$499$175
Getty Images
In stockDETAILS
Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Editorial #:
459118974
Collection:
Bloomberg
Date created:
November 17, 2014
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
UK ALLERGAN ACTAVIS
Max file size:
4000 x 2667 px (13.33 x 8.89 in) - 300 dpi - 3 MB